Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma (2015)
- Authors:
- Autor USP: ULRICH, ALEXANDER HENNING - IQ
- Unidade: IQ
- DOI: 10.1002/cyto.a.22715
- Subjects: BIOMARCADORES; NANOPARTÍCULAS
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DELAC, Mateja et al. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma. Cytometry, p. 1-11, 2015Tradução . . Disponível em: https://doi.org/10.1002/cyto.a.22715. Acesso em: 09 jan. 2026. -
APA
Delac, M., Motaln, H., Ulrich, H., & Lah, T. T. (2015). Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma. Cytometry, 1-11. doi:10.1002/cyto.a.22715 -
NLM
Delac M, Motaln H, Ulrich H, Lah TT. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma [Internet]. Cytometry. 2015 ; 1-11.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1002/cyto.a.22715 -
Vancouver
Delac M, Motaln H, Ulrich H, Lah TT. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma [Internet]. Cytometry. 2015 ; 1-11.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1002/cyto.a.22715 - Aluminum-induced alterations of purinergic signalling in embryonic neural progenitor cells
- Roles of kinins in the nervous system
- Trends in stem cell proliferation and cancer research
- Parkinson's disease: genetics, mechanisms and diagnosis
- Directed differentiation of neural progenitors into neurons is accompanied by altered expression of P2X purinergic receptors
- Intracellular calcium measurements for munctional characterization of neuronal phenotypes
- Optimization of SELEX: comparison of different methods for monitoring the progress of in vitro selection of aptamers
- Retinoic acid-treated pluripotent stem cells undergoing neurogenesis present increased aneuploidy and micronuclei formation
- Scaffolds and magnetic stimulation to guide embryonic stem cell differentiation
- A novel physiological property of snake bradykinin-potentiating peptides-reversion of MK-801 inhibition of nicotinic acetylcholine receptors
Informações sobre o DOI: 10.1002/cyto.a.22715 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
